THAR

Tharimmune, Inc., a biotechnology company, engages in developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. Its early-stage immuno-oncology pipeline includes antibodies targeting epitopes against validated targets in various solid tumors. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is based in Bridgewater, New Jersey. Show More...